Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):2225–2235. doi: 10.1161/ATVBAHA.118.311023

Figure 1. Plasma TMAO levels in relation to subsequent cardiovascular events in patients with ischemic stroke from the first study.

Figure 1

In the first cohort, plasma levels of TMAO (A) but not choline (B) dose-dependently trace the risk of incident CVE including myocardial infarction, stroke and death.